The Role of L-arginine in Cardiovascular Health
¹®Çå : US Pharmacist 1999³â 11¿ùÈ£
ºÎõ DIPȸ¿ø Á¤Çý¼±
Áöµµ±³¼ö: Á¶À±¼º
¿ì¸® ¸ö¼Ó¿¡´Â EDRF¶ó´Â µ¿¸Æ Ç÷°ü È®ÀåÀÛ¿ë ÀÎÀÚ°¡ ÀÖ´Ù°í ¾Ë·ÁÁ® ¿Ô´Âµ¥ ÃÖ±Ù¿¡ ÀÌ°ÍÀÌ NO ¶ó´Â free radical (¹°Áú ºÐÀÚÁß ¿ÜÅ丮 ÀüÀÚ¸¦ ÇÔÀ¯ÇÏ´Â ºÐÀÚ¸¦ ¶æÇÔ)±âü·Î ÆǸíµÇ¾ú´Ù.
ÀÌ NO´Â ´ë½Ä¼¼Æ÷¿¡ Á¸ÀçÇϴµ¥ ´ë½Ä¼¼Æ÷ÀÇ ¼¼Æ÷µ¶ÀÛ¿ë(»ì±ÕÀÛ¿ë)À» ÇÏ´Â ¼ººÐÀ¸·Î º¸°íµÇ¾ú´Ù. ´ë½Ä¼¼Æ÷´Â ÀÎü³»¿¡ Á¸ÀçÇÏ´Â »ì±Õ¼º ÀÖ´Â ¸é¿ª±â´ÉÀ» °®´Â ¼¼Æ÷ÀÇ ÀÏÁ¾ÀÓ.
NOÀÇ ±âŸ ÀÛ¿ëÀ¸·Î´Â Ç÷°ü È®À强, ¸é¿ª ¹ÝÀÀ, ¹éÇ÷±¸¿Í Ç÷¼ÒÆÇÀÇ À¯Âø¼º, ½Å°æ Àü´Þ ÇùÁ¶ µîÀÇ »ý¸® ÀÛ¿ëÀÌ ÀÖ´Ù. ÀÎü ¹× ±âŸ Æ÷À¯µ¿¹°ÀÇ Ã¼³»¿¡¼´Â »ó±â¿Í °°Àº NO (free radical) ¸¦ »ý»êÇϴµ¥ ±×¿ø·á°¡ L-arginineÀ̶ó´Â ¾Æ¹Ì³ë»êÀÌ´Ù.
#Áõ·Ê 1) ¸»ÃÊ µ¿¸Æ (ƯÈ÷ ¾ó±¼, ¼Õ, ¹ß) Áúȯ ȯÀÚ¿¡°Ô L-arginine 8g¾¿ ÇÏ·ç 2ȸ 14ÀÏ°£ Åõ¿©ÇÑ °á°ú ¾ÆÇÄÀ» ´À³¢Áö ¾Ê°í °ÉÀ» ¼ö ÀÖ´Â °Å¸®°¡ 1.5¹è·Î °³¼±µÇ¾ú´Ù°í Áõ¸íµÇ¾ú´Ù (¼Õ¹ßÀÌ ¾ÆÇÁ´Ù°í ´À³¢´Â °ÍÀº ±× ºÎÀ§ Ç÷°üÀÌ Á¶±Ý ¸·Çô¼ ¿À´Â Áõ»óÀÓ)
#Áõ·Ê 2) °ü»óµ¿¸Æ ÁúȯÀÌ ÀÖ´Â Çù½ÉÁõ ȯÀÚ¿¡°Ô L-ArginineÀ» ÇÏ·ç 9g¾¿ °æ±¸Åõ¿© 6°³¿ù ÇÑ °á°ú ½ÉÀå Ç÷°üÈ®ÀåÀ²ÀÌ 149% °³¼±µÇ°í Çù½ÉÁõ ¹ßÀÛ Áõ»óÀÌ 70% °¨¼ÒµÇ¾ú´Ù: ¿©±âÀÇ Ç÷°ü È®ÀåÀº acetylcholineºÐºñ Áõ°¡¿¡ ÀÇÇÑ °ÍÀÓ ÀÇ¾à ½ÄÇ°ÀÇ ÇüÅ·ΠarginineÀ» ¼·ÃëÇÒ ¼ö ÀÖ´Â Á¦Ç°ÀÌ ÃÖ±Ù¿¡ °³¹ßµÇ¾ú´Ù ÀÌ°ÍÀºL- arginine°ú ´Ù¸¥ ¸¹Àº Ç×»êÈÁ¦, ºñŸ¹Î, ¼¶À¯¼Ò µîÀ» ÇÔÀ¯ÇÑ´Ù.
ÀÌµé ±âŸ ¼ººÐ(Ç×»êÈÁ¦, ºñŸ¹Î, ¼¶À¯¼Ò)µéµµ ½ÉÇ÷°ü ÁúȯÀ» ¾Î´Â ȯÀÚ¿¡°Ô ¾î´À Á¤µµ À¯ÀÍÇÔÀÌ Áõ¸íµÇ¾úÀ½.
L-arginine ÇÔÀ¯ Á¦Á¦ ; ·¹³ì½ÇÁ¤ (Áø¾çÁ¦¾à), ¾Ë±â³ªÁ¦ÁÖ»ç(»õÇÑÁ¦¾à), º¹ÇÕÇï¹Î ¿¬ÁúÄ°¼¿ (µ¿È¾àÇ°), ÇìÆ÷½º ½Ã·´ (Á¶¾ÆÁ¦¾à),
¸¹Àº ¿¬±¸µéÀÌ L- arginineÀ» º¸ÃæÇÔÀ¸·Î¼ NO·Î ½ÉÇ÷°üÀÌ °Ç°ÇÏ°Ô µÉ °¡´É¼ºÀ» ºÐ¸íÈ÷ Áõ¸íÇÏ¿´´Ù.
L- arginine¿ä¹ý°ú °ü·ÃµÈ ºÎÀÛ¿ëÀº ±ØÈ÷ Àû´Ù. ´Ü, ÇöÀç ¾Ç¼º Á¾¾ç,½ÉÇÑ °¨¿°Áõ, ´ç´¢¼º ¸Á¸·ÁõÀ» ¾Î´Â °æ¿ì´Â º¹¿ëÀ» ÇÇÇÔ. ȯÀÚ´Â L- arginineÀÌ ÇÔÀ¯µÈ Á¦Ç°À» ½ÉÇ÷°ü Áúȯ¿¡ »ç¿ëÇÏ´Â °Í¿¡ ´ëÇؼ ±×µéÀÇ °Ç° °ü¸® Á¦°øÀÚµé(¾à»ç, ÀÇ»ç)°ú »ó´ãÀ» ¹Ýµå½Ã ÇؾßÇÑ´Ù.
¸¹Àº ¿¬±¸ º¸°í´Â L-arginineÀ» ÀûÀýÈ÷ º¹¿ëÇϸé ü³»¿¡ NO»ý»ê·®ÀÌ Áõ°¡ÇÏ¿© Ç÷°ü ¼öÃ༺ ȯÀÚÀÇ Áõ»óÀ» °³¼±½Ãų ¼ö ÀÖ´Ù°í ±â¼úÇÏ°í ÀÖ´Ù.
The endogenous arterial vasodilator ¡°endothelium- derived relaxing factor (EDRFwas determined to be chemically identical to the free radical gas nitric oxide (NO).
Known to be present in macrophages, NO is thought to mediate a number of macrophage cytotoxic actions.
Endogenous NO is believed to mediate many diverse physiological processes including vasorelaxation, immune responses, adhesion of leukocytes and platelets, and neurotransmission. The amino acid L-arginine is the precursor for the synthesis of NO in mammals. Patients with peripheral arterial disease also benefit from L-arginine supplemen tation (8g BID,14days) as eviden< ÀúÀÛ±ÇÀÚ © ¾à±¹½Å¹® ¹«´ÜÀüÀç ¹× Àç¹èÆ÷±ÝÁö > |
|
|
|
|
ÀÌ ±â»ç¿¡ ´ëÇÑ ´ñ±Û À̾߱â (0) |
|
|
|